Jun 1, 2026 06:55AM

May 13, 2026 04:05PM

Mar 17, 2026 01:51PM

Mar 17, 2026 12:06PM

Mar 17, 2026 09:00AM

Mar 16, 2026 11:07AM

Mar 16, 2026 06:52AM H.C. Wainwright Reiterates Neutral Rating on Inovio Pharmaceuticals (INO)

Mar 13, 2026 09:00AM

Mar 13, 2026 07:08AM

Mar 12, 2026 04:05PM

Mar 11, 2026 12:06PM

Mar 10, 2026 06:13PM

Mar 10, 2026 09:00AM

Mar 9, 2026 01:25PM Portnoy Law Firm Announces Class Action on Behalf of Inovio Pharmaceuticals, Inc. Investors

Mar 6, 2026 04:00PM

Mar 5, 2026 12:08PM

Mar 3, 2026 12:00PM

Mar 3, 2026 09:00AM

Mar 2, 2026 09:00AM

Feb 26, 2026 04:00PM

Feb 26, 2026 12:09PM DEADLINE ALERT for TCPC, ORCL, PSFE, and INO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Feb 26, 2026 12:00PM

Feb 26, 2026 10:41AM

Feb 25, 2026 12:00PM

Feb 24, 2026 12:00PM

Feb 24, 2026 10:16AM

Feb 24, 2026 09:00AM

Feb 24, 2026 08:00AM Holzer & Holzer, LLC Reminds INO Investors of the April 7, 2026 Lead Plaintiff Deadline in the Inovio Pharmaceuticals, Inc. Securities Class Action

Feb 23, 2026 01:06PM

Feb 23, 2026 04:04AM

Feb 23, 2026 04:02AM

Feb 20, 2026 02:37PM

Feb 20, 2026 12:09PM

Feb 20, 2026 04:27AM

Feb 20, 2026 02:21AM INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Feb 19, 2026 10:22AM

Feb 19, 2026 09:15AM

Feb 18, 2026 05:06PM

Feb 17, 2026 12:58PM

Feb 13, 2026 03:03PM

Feb 13, 2026 12:08PM

Dec 30, 2025 03:43PM Jefferies on Inovio Pharmaceuticals (INO): 'Our near-term focus is on Type B outcome expected in ~50 days + ~30 days meeting minutes'

Dec 30, 2025 06:39AM

Dec 29, 2025 08:05AM

Dec 29, 2025 08:05AM

Dec 21, 2025 04:00AM

Nov 10, 2025 04:05PM

Nov 3, 2025 08:05AM

Nov 3, 2025 08:05AM INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults

Sep 25, 2025 08:05AM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All